These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10923050)

  • 21. Bicistronic lentiviral vector corrects beta-hexosaminidase deficiency in transduced and cross-corrected human Sandhoff fibroblasts.
    Arfi A; Bourgoin C; Basso L; Emiliani C; Tancini B; Chigorno V; Li YT; Orlacchio A; Poenaru L; Sonnino S; Caillaud C
    Neurobiol Dis; 2005 Nov; 20(2):583-93. PubMed ID: 15953731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Compound heterozygosity with two novel mutations in the HEXB gene produces adult Sandhoff disease presenting as a motor neuron disease phenotype.
    Yoshizawa T; Kohno Y; Nissato S; Shoji S
    J Neurol Sci; 2002 Mar; 195(2):129-38. PubMed ID: 11897243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In situ assessment of beta-hexosaminidase activity.
    Lacorazza HD; Jendoubi M
    Biotechniques; 1995 Sep; 19(3):434-40. PubMed ID: 7495557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sandhoff disease in the Turkish population.
    Ozkara HA; Topçu M; Renda Y
    Brain Dev; 1997 Nov; 19(7):469-72. PubMed ID: 9408593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic correction in microglia derived from Sandhoff disease model mice.
    Tsuji D; Kuroki A; Ishibashi Y; Itakura T; Itoh K
    J Neurochem; 2005 Sep; 94(6):1631-8. PubMed ID: 16092933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of two point mutations present in each HEXB allele of patients with adult GM2 gangliosidosis (Sandhoff disease) homozygosity for the Ile207-->Val substitution is not associated with a clinical or biochemical phenotype.
    Redonnet-Vernhet I; Mahuran DJ; Salvayre R; Dubas F; Levade T
    Biochim Biophys Acta; 1996 Nov; 1317(2):127-33. PubMed ID: 8950198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Widespread distribution of beta-hexosaminidase activity in the brain of a Sandhoff mouse model after coinjection of adenoviral vector and mannitol.
    Bourgoin C; Emiliani C; Kremer EJ; Gelot A; Tancini B; Gravel RA; Drugan C; Orlacchio A; Poenaru L; Caillaud C
    Gene Ther; 2003 Oct; 10(21):1841-9. PubMed ID: 12960974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A second, large deletion in the HEXB gene in a patient with infantile Sandhoff disease.
    Zhang ZX; Wakamatsu N; Akerman BR; Mules EH; Thomas GH; Gravel RA
    Hum Mol Genet; 1995 Apr; 4(4):777-80. PubMed ID: 7633435
    [No Abstract]   [Full Text] [Related]  

  • 29. Natural history and inherited disorders of a lysosomal enzyme, beta-hexosaminidase.
    Neufeld EF
    J Biol Chem; 1989 Jul; 264(19):10927-30. PubMed ID: 2525553
    [No Abstract]   [Full Text] [Related]  

  • 30. Characterization of two HEXB gene mutations in Argentinean patients with Sandhoff disease.
    Brown CA; McInnes B; de Kremer RD; Mahuran DJ
    Biochim Biophys Acta; 1992 Oct; 1180(1):91-8. PubMed ID: 1390948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Adult form of GM2-gangliosidosis: a man and 2 sisters with hexosaminidase-A and -B deficiency (Sandhoff disease) and literature review].
    Schnorf H; Bosshard NU; Gitzelmann R; Spycher MA; Isler P; Waespe W
    Schweiz Med Wochenschr; 1996 May; 126(18):757-64. PubMed ID: 8693300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific induction of macrophage inflammatory protein 1-alpha in glial cells of Sandhoff disease model mice associated with accumulation of N-acetylhexosaminyl glycoconjugates.
    Tsuji D; Kuroki A; Ishibashi Y; Itakura T; Kuwahara J; Yamanaka S; Itoh K
    J Neurochem; 2005 Mar; 92(6):1497-507. PubMed ID: 15748167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GM2 gangliosidosis with a motor neuron disease phenotype: clinical heterogeneity of hexosaminidase deficiency disease.
    Federico A
    Adv Exp Med Biol; 1987; 209():19-23. PubMed ID: 2953177
    [No Abstract]   [Full Text] [Related]  

  • 34. Molecular basis of an adult form of Sandhoff disease: substitution of glutamine for arginine at position 505 of the beta-chain of beta-hexosaminidase results in a labile enzyme.
    Bolhuis PA; Ponne NJ; Bikker H; Baas F; Vianney de Jong JM
    Biochim Biophys Acta; 1993 Sep; 1182(2):142-6. PubMed ID: 8357844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An inversion of 25 base pairs causes feline GM2 gangliosidosis variant.
    Martin DR; Krum BK; Varadarajan GS; Hathcock TL; Smith BF; Baker HJ
    Exp Neurol; 2004 May; 187(1):30-7. PubMed ID: 15081585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early and severe sensory loss in three adult siblings with hexosaminidase A and B deficiency (Sandhoff disease).
    Schnorf H; Gitzelmann R; Bosshard NU; Spycher M; Waespe W
    J Neurol Neurosurg Psychiatry; 1995 Nov; 59(5):520-3. PubMed ID: 8530938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sandhoff disease--a case report of 3 siblings and a review of potential therapies.
    Tay SK; Low PS; Ong HT; Loke KY
    Ann Acad Med Singap; 2000 Jul; 29(4):514-7. PubMed ID: 11056783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of premature stop codons on mRNA levels in infantile Sandhoff disease.
    Zhang ZX; Wakamatsu N; Mules EH; Thomas GH; Gravel RA
    Hum Mol Genet; 1994 Jan; 3(1):139-45. PubMed ID: 8162015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Late infantile and juvenile form of GM2-gangliosidosis variant B1].
    Eirís J; Chabás A; Coll MJ; Castro-Gago M
    Rev Neurol; 1999 Sep 1-15; 29(5):435-8. PubMed ID: 10584247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GM2-gangliosidosis, Type 2 (Sandhoff disease).
    Varadkar AM; Mahale SD; Suchak RH; Patel ZM; Dhareshwar SS; Ambani LM
    Indian Pediatr; 1983 Apr; 20(4):302-5. PubMed ID: 6225733
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.